The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa).
 
Sean Matthew McBride
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
 
Michael J. Zelefsky
No Relationships to Disclose
 
Daniel Eidelberg Spratt
No Relationships to Disclose
 
Marisa Kollmeier
No Relationships to Disclose
 
Susan F. Slovin
Consulting or Advisory Role - Bayer
 
Jahan Aghalar
No Relationships to Disclose
 
Jason W.D. Hearn
No Relationships to Disclose
 
Robert Benjamin Den
Consulting or Advisory Role - GenomeDx
Speakers' Bureau - Bayer
Research Funding - GenomeDx; Medivation/Astellas
Travel, Accommodations, Expenses - GenomeDx
 
Curtiland Deville
No Relationships to Disclose
 
Karen Borofsky
No Relationships to Disclose
 
Han Xiao
No Relationships to Disclose
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca; Clovis Oncology; GlaxoSmithKline (Inst); Zenith Epigenetics
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Clovis Oncology; Ferring; Janssen Research & Development; Onclive; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Asterias Biotherapeutics; Onclive; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
 
Dana E. Rathkopf
Consulting or Advisory Role - Genentech/Roche; Janssen Oncology; TRACON Pharma
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)